Literature DB >> 10592655

Natural history and disease manifestations of hepatitis C infection.

D Theodore1, M W Fried.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10592655     DOI： 10.1007/978-3-642-59605-6_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  9 in total

1.  Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line.

Authors:  Marc P Windisch; Michael Frese; Artur Kaul; Martin Trippler; Volker Lohmann; Ralf Bartenschlager
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

2.  Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection.

Authors:  J Encke; J Findeklee; J Geib; E Pfaff; W Stremmel
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

3.  Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.

Authors:  Jan Krönke; Ralf Kittler; Frank Buchholz; Marc P Windisch; Thomas Pietschmann; Ralf Bartenschlager; Michael Frese
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

4.  The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A.

Authors:  Karla J Helbig; Nicholas S Eyre; Evelyn Yip; Sumudu Narayana; Kui Li; Guillaume Fiches; Erin M McCartney; Rohit K Jangra; Stanley M Lemon; Michael R Beard
Journal:  Hepatology       Date:  2011-11       Impact factor: 17.425

5.  Genetic vaccination with Flt3-L and GM-CSF as adjuvants: Enhancement of cellular and humoral immune responses that results in protective immunity in a murine model of hepatitis C virus infection.

Authors:  Jens Encke; Jomo Bernardin; Jasmin Geib; Gocha Barbakadze; Raymond Bujdoso; Wolfgang Stremmel
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

6.  Development and Applications of VSV Vectors Based on Cell Tropism.

Authors:  Hideki Tani; Shigeru Morikawa; Yoshiharu Matsuura
Journal:  Front Microbiol       Date:  2012-01-18       Impact factor: 5.640

7.  Small interfering RNA targeted to stem-loop II of the 5' untranslated region effectively inhibits expression of six HCV genotypes.

Authors:  Ramesh Prabhu; Robert F Garry; Srikanta Dash
Journal:  Virol J       Date:  2006-11-27       Impact factor: 4.099

8.  Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.

Authors:  Ekaterina Alekseeva; Irina Sominskaya; Dace Skrastina; Irina Egorova; Elizaveta Starodubova; Eriks Kushners; Marija Mihailova; Natalia Petrakova; Ruta Bruvere; Tatyana Kozlovskaya; Maria Isaguliants; Paul Pumpens
Journal:  Genet Vaccines Ther       Date:  2009-06-08

9.  Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States.

Authors:  Christopher E Bell; Marc F Botteman; Xin Gao; Joel L Weissfeld; Maarten J Postma; Chris L Pashos; Darrell Triulzi; Ulf Staginnus
Journal:  Clin Ther       Date:  2003-09       Impact factor: 3.393
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.